NOVACINA
Dead / Abandoned — Abandoned — no statement of use filed (as of 24 Nov 2025)
What this means for you
This application is over — abandoned 24 Nov 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97759722
- Mark type
- Stylized text
- Filed
- 18 Jan 2023
- Published for opposition
- 27 Feb 2024
- Abandoned
- 24 Nov 2025
- Attorney of record
- Lisel M. Ferguson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for use by humans, namely, sterile injectable pharmaceutical preparations for the treatment of dehydration, low potassium levels, bleeding, infection, and pain
- Class 040 — Treatment of materials: Custom manufacture of therapeutics, disinfectants, diluents, and vaccines for the treatment of dehydrations, low potassium levels, bleeding, infection and pain
- Class 042 — Scientific and technological services: Scientific research and development of therapeutics, disinfectants, diluents, and vaccines for the treatment of dehydrations, low potassium levels, bleeding, infection and pain
Owner
- Bridgewest International Holdings LLC, Miami, FL, US
- Bridgewest International Holdings LLC, Miami, FL, US
Prosecution history
- 24 Nov 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 24 Nov 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 16 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Oct 2025 — SOU EXTENSION 2 GRANTED
- 22 Apr 2025 — SOU EXTENSION 2 FILED
- 14 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Jul 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 21 Jul 2025 — NOTICE OF REVIVAL - E-MAILED
- 21 Jul 2025 — PETITION TO REVIVE-GRANTED
- 21 Jul 2025 — TEAS PETITION TO REVIVE RECEIVED
- 31 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 31 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 31 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Oct 2024 — SOU EXTENSION 1 GRANTED